The retinoid family is the most well-established class of topical actives in skincare. Almost every claim a brand makes about anti-aging benefit traces, somewhere upstream, back to a study on a retinoid. Most consumers, when they buy a retinoid product, are buying it without knowing which form of retinoid is in it, what dose, or how that dose translates to the dose that drove the underlying clinical evidence.
Six retinoids dominate the consumer and prescription markets. They differ in potency by roughly two orders of magnitude. A user who is unimpressed with their retinol may be using a product whose effective dose is 1/40th of the dose that drove the headline results they read about. The molecule matters.
How Retinoids Work, In One Paragraph
All retinoids work by the same mechanism. They bind to retinoic acid receptors (RARs) in the nucleus of skin cells, which changes the transcription of specific genes — upregulating collagen synthesis, normalizing keratinocyte turnover, inhibiting metalloproteinase activity that breaks down existing collagen, and reducing melanosome transfer. Only one molecule actually binds the receptor: retinoic acid, also known as tretinoin. Every other retinoid is a precursor that the skin enzymatically converts into retinoic acid through a chain of oxidation steps. The further upstream a retinoid sits in that chain, the more conversion steps are required, and the more potency is lost at each step.
This is the central organizing principle. Potency tracks conversion distance. Tolerability is the inverse of potency.
Tretinoin (All-Trans Retinoic Acid)
The reference molecule. Binds RAR directly with no conversion needed. Prescription-only in the United States (in most other countries, sold over the counter at 0.025%). Standard prescription concentrations are 0.025%, 0.05%, and 0.1%, with 0.025% being the most commonly prescribed and 0.05% being the strongest concentration most users tolerate over the long term.
Evidence base: enormous. The majority of the foundational retinoid studies — Kligman's wrinkle studies, the photoaging trials of the 1990s, every comparative efficacy study against newer retinoids — used tretinoin as the reference arm. When the literature reports that retinoids reduce fine lines, improve photoaging, normalize keratinocyte turnover, and reduce acne incidence, the strongest version of that evidence is from tretinoin studies.
Tradeoff: the highest irritation profile of any topical retinoid. Most users experience a 4-to-8-week retinization period of dryness, flaking, and increased sensitivity. About half of users who start tretinoin quit before week 12. The drug works, but only for users who tolerate the front-end cost.
Best for: users with established skin tolerance to retinoids, an existing acne or photoaging concern, and the discipline to apply consistently through the retinization period.
Retinaldehyde (Retinal)
Two conversion steps removed from retinoic acid (retinaldehyde → retinoic acid is a single oxidation, but the precursor itself is already partially oxidized). The closest over-the-counter retinoid to tretinoin in potency. Concentration range: 0.05% to 0.1% in well-formulated consumer products, occasionally higher in dermatologist-distributed brands.
Evidence base: smaller than tretinoin but real. Head-to-head studies against retinol consistently show retinaldehyde delivering greater improvements in fine lines and photoaging at lower concentrations, with comparable irritation profiles. The clinical literature supports retinaldehyde as a meaningful step up from retinol — not as potent as tretinoin, but close enough that the irritation reduction is worth the trade for users who cannot tolerate the prescription.
Tradeoff: unstable in formulation. Retinaldehyde oxidizes rapidly on exposure to air and light, which is why most products containing it use airless packaging and tinted glass. Improperly formulated retinaldehyde products may contain less active ingredient than the label indicates by the time the bottle is opened.
Best for: experienced retinoid users seeking near-prescription efficacy without a prescription. Also the right choice for users with sensitive skin who want to start at the highest tolerable dose.
Retinol
The most common over-the-counter retinoid. Two oxidation steps removed from retinoic acid: retinol → retinaldehyde → retinoic acid. Per-molecule potency is approximately 1/20th of tretinoin and roughly 1/10th of retinaldehyde in cell-culture and skin-penetration studies.
Concentration range in consumer products: 0.1% to 1%, with 0.5% being the most common. The 1% concentration delivers about the same effective receptor binding as 0.05% retinaldehyde, which delivers about the same as 0.025% tretinoin. The pyramid is real, and the doses across the pyramid track each other reasonably well.
Evidence base: substantial, though smaller than tretinoin. The most reliable retinol studies use 0.4% to 1% concentrations over 12 to 24 weeks, with biopsy-confirmed endpoints. Many consumer retinol products are formulated at 0.1% to 0.3%, which is below the concentration that drives the published evidence. A 0.1% retinol product is not a weaker version of the studied product; it is a different product at a dose that may not produce measurable change.
Tradeoff: stability is intermediate. Retinol degrades more slowly than retinaldehyde but more quickly than esters like retinyl palmitate. Most consumer retinol products use airless or tinted packaging. Open-jar packaging is a tell that the product has either been formulated with the assumption that potency loss is acceptable or with an ester that is not actually retinol.
Best for: first-time retinoid users with intact barrier function. Also reasonable for long-term maintenance after a stronger retinoid has done the initial remodeling work.
Adapalene
A synthetic retinoid with a different chemical structure than the others on this list. Originally developed and approved as a prescription drug for acne; the United States moved 0.1% adapalene to over-the-counter status in 2016. The 0.3% concentration remains prescription-only.
Mechanism: binds RAR with selective affinity for certain receptor subtypes. The result is comparable efficacy to tretinoin on acne endpoints, with a slightly different anti-aging profile (somewhat weaker on fine line endpoints, comparable on dyschromia).
Evidence base: large for acne, smaller for anti-aging. Head-to-head against tretinoin 0.025%, adapalene 0.1% shows roughly comparable acne lesion reduction with significantly less irritation. This is a real advantage for users whose primary concern is acne and whose secondary concern is tolerability.
Tradeoff: less anti-aging evidence than tretinoin. If your concern is photoaging rather than acne, tretinoin or retinaldehyde may be a better choice.
Best for: acne-prone users who want a tolerable, accessible, OTC option with strong evidence behind it. The lower irritation profile makes it a defensible first retinoid for users who have not tried any retinoid before.
Hydroxypinacolone Retinoate (HPR / Granactive)
A retinoid ester that binds RAR directly without enzymatic conversion. The marketing claim is "tretinoin-like efficacy without irritation." The reality is more measured.
Mechanism: HPR binds RAR with affinity that is meaningfully lower than tretinoin's, but it does so without needing the skin to convert it. The result is a retinoid that delivers a smaller dose of receptor activation per molecule applied but does so without the burst of free retinoic acid that drives irritation in tretinoin users.
Evidence base: limited. A handful of consumer perception studies and a few open-label clinical evaluations exist. Head-to-head trials against tretinoin or retinaldehyde at matched doses are sparse. The molecule appears to do something — the in-vitro receptor binding data is real — but the clinical literature is not at the level required to support the strongest marketing claims.
Tradeoff: low irritation, but also lower confidence in the magnitude of effect. A user who tolerates retinaldehyde is likely getting more dermal remodeling per application from retinaldehyde than from HPR at the concentrations typically formulated.
Best for: users who cannot tolerate any traditional retinoid and want a low-irritation entry point. Also useful as a stepping stone for users who want to build tolerance before moving up to retinol or retinaldehyde.
Retinyl Palmitate (And Other Esters)
Three oxidation steps removed from retinoic acid: retinyl palmitate → retinol → retinaldehyde → retinoic acid. Per-molecule potency is approximately 1/100th of tretinoin in conversion-corrected receptor binding studies.
Evidence base: small. Retinyl palmitate is included in many consumer moisturizers and serums, but the clinical literature does not show meaningful skin remodeling at the concentrations typically used. The molecule is stable, cheap, and pleasant to formulate with, which is why it appears in many products. None of those are reasons to expect it to do much.
Tradeoff: it is, for practical purposes, an inactive ingredient at concentrations below 1%. Above 1%, it begins to behave like a very weak retinol.
Best for: not much, honestly. If a product contains retinyl palmitate as its only retinoid, treat the product as a moisturizer that has been allowed to claim retinoid status without supporting one.
How To Choose
Three decision rules.
First: anchor on your concern. Acne and severe photoaging benefit most from tretinoin or adapalene at the prescription level. Moderate photoaging and general anti-aging benefit from retinaldehyde or well-dosed retinol. Mild concern with very sensitive skin can start with HPR and step up.
Second: anchor on your tolerance. If you have used a retinoid before and tolerated it, you can move up the pyramid. If you have not, start one level below where you think you should — every retinoid is more irritating in practice than the brochure suggests, and starting too high is the most common reason users quit.
Third: anchor on the formulation, not just the molecule. A 0.5% retinol in airless packaging from a brand that publishes stability data is a different product than a 0.5% retinol in a translucent jar from a brand that does not. The label is a starting point. The full story is the molecule, the concentration, the vehicle, and the packaging.
The retinoid family is the most reliable category of topical actives in skincare. Used well, it does what it says. The user's job is to figure out which member of the family fits the dose and tolerance window they are actually operating in — which is rarely the highest one available, and rarely the lowest one either.